Teva Rises on Positive Test Results for Migraine Treatment - TheStreet
Teva's Trial Results finds drug could slow Huntington's disease - Jewish Business News
Teva cuts forecast for 2017 amid competition to flagship Copaxone drug | The Times of Israel
Teva Reports Second Quarter 2021 Financial Results
Teva Pharmaceutical Industries Ltd. - Yesterday we shared Teva's Q1 2020 financial results. View the highlights of our contributions to #COVID19 efforts worldwide, focusing on employee safety and ensuring that quality medicines
The Teva Pharmaceutical Industries Limited (NYSE:TEVA) Yearly Results Are Out And Analysts Have Published New Forecasts
Teva Collection
Teva Reports First Quarter 2021 Financial Results | Business Wire
Teva maintains outlook despite lagging Q1 sales for generics, Copaxone
Teva shares rise in Tel Aviv as migraine results buoy investors | The Times of Israel
Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance at 8 a.m. ET on February 10, 2021 | Business Wire